It looks like you're offline.
Open Library logo
additional options menu

MARC Record from marc_columbia

Record ID marc_columbia/Columbia-extract-20221130-029.mrc:124606314:4678
Source marc_columbia
Download Link /show-records/marc_columbia/Columbia-extract-20221130-029.mrc:124606314:4678?format=raw

LEADER: 04678cam a2200661 i 4500
001 14408352
005 20200108095229.0
008 181024t20192019nyu b 001 0 eng
010 $a 2018048368
024 $a99982749991
035 $a(OCoLC)on1057377213
040 $aDLC$beng$erda$cDLC$dOCLCO$dBDX$dOCLCF$dMLY$dJNE$dKYC$dUAP$dGO3$dSLV$dZGR$dYDX$dOCLCO$dBUR$dIUK$dVP@$dDLC$dOCL$dOCLCO$dTXSCH$dNLM$dOCLCO
019 $a1089732490$a1101645875
020 $a9780062338785$q(hardback)
020 $a0062338781$q(hardback)
020 $a9780062338792
020 $a006233879X
020 $a9780062917645
020 $a0062917641
020 $a9780062917652
020 $a006291765X
035 $a(OCoLC)1057377213$z(OCoLC)1089732490$z(OCoLC)1101645875
037 $bHarpercollins, 53 Glenmaura National Blvd Ste 300, Moosaic, PA, USA, 18507-2132$nSAN 200-2086
042 $apcc
043 $an-us---
050 00 $aRS55.2$b.E23 2019
060 00 $a2019 E-782
060 10 $aQV 771
082 00 $a615.1$223
100 1 $aEban, Katherine,$eauthor.
245 10 $aBottle of lies :$bthe inside story of the generic drug boom /$cKatherine Eban.
250 $aFirst edition.
264 1 $aNew York, NY :$bEcco, an imprint of HarperCollins Publishers,$c[2019]
264 4 $c©2019
300 $axxiv, 482 pages ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
338 $avolume$bnc$2rdacarrier
504 $aIncludes bibliographical references (pages [421]-461) and index.
520 $a"Many have hailed the widespread use of generic drugs as one of the most important public-health developments of the twenty-first century. Today, almost 90 percent of our pharmaceutical market is comprised of generics, the majority of which are manufactured overseas. We have been reassured by our doctors, our pharmacists and our regulators that generic drugs are identical to their brand-name counterparts, just less expensive. But is this really true? Katherine Eban's Bottle of Lies exposes the deceit behind generic-drug manufacturing--and the attendant risks for global health. Drawing on exclusive accounts from whistleblowers and regulators, as well as thousands of pages of confidential FDA documents, Eban reveals an industry where fraud is rampant, companies routinely falsify data, and executives circumvent almost every principle of safe manufacturing to minimize cost and maximize profit, confident in their ability to fool inspectors. Meanwhile, patients unwittingly consume medicine with unpredictable and dangerous effects. The story of generic drugs is truly global. It connects middle America to China, India, sub-Saharan Africa and Brazil, and represents the ultimate litmus test of globalization: what are the risks of moving drug manufacturing offshore, and are they worth the savings?" -- Dust jacket.
505 0 $aPart I: Shifting ground. The man who saw further ; The gold rush ; A slum for the rich ; The language of quality ; Red flags -- Part II: India rises. Freedom fighters ; One dollar a day ; A clever way of doing things ; The assignment -- Part III: A cat-and-mouse business. The global cover-up ; Map of the world ; The pharaoh of pharma -- Part IV: Making a case. Out of the shadows ; "Do not give to FDA" ; "How big is the problem?" ; Diamond and ruby ; "You just don't get it" -- Part V: Detectives in the dark. Congress wakes up ; Solving for X ; A test of endurance ; A deep, dark well ; The $600 million jacket -- Part VI: The watershed. The light switch ; We are the champions ; Crashing files ; The ultimate testing laboratory -- Part VII: Reckonings. Flies too numerous to count ; Standing.
650 0 $aGeneric drugs$xQuality control.
650 0 $aDrug adulteration.
650 0 $aPharmaceutical industry$xCorrupt practices$zUnited States.
650 12 $aDrugs, Generic$xstandards.
650 12 $aFraud.
650 22 $aDrug Industry$xstandards.
650 22 $aDrug Industry$xlegislation & jurisprudence.
650 22 $aGovernment Regulation.
650 22 $aDrug Contamination$xlegislation & jurisprudence.
650 7 $aBUSINESS & ECONOMICS / Industries / Pharmaceutical & Biotechnology.$2bisacsh
650 7 $aMEDICAL / Pharmacology.$2bisacsh
650 7 $aPharmaceutical industry$xCorrupt practices.$2fast$0(OCoLC)fst01060133
650 7 $aDrug adulteration.$2fast$0(OCoLC)fst00898652
651 7 $aUnited States.$2fast$0(OCoLC)fst01204155
650 7 $aGeneric drugs.$2sears
776 08 $iOnline version:$aEban, Katherine, author.$tBottle of lies$bFirst edition.$dNew York, NY : Ecco, [2018]$z9780062338808$w(DLC) 2018052051
852 00 $bglx$hRS55.2$i.E23 2019